“atlas-venture” Archives

in
Entry Author Date Location
Magenta Nabs More Cash, Licenses Drug To Boost Transplant Pipeline 05/02/17 Boston
ZappRx Gets $25M to Push E-Prescription Tools for Specialty Meds 04/20/17 Boston
Scott Gottlieb On Tap to Lead FDA, and Biopharma Exhales 03/10/17 National
Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics 03/08/17 Boston
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Meet the 15 New Early-Stage Venture Funds in Boston Tech: Slideshow 01/30/17 Boston
Just Four Months After Series A, Delinia Sells to Celgene For $300M 01/26/17 Boston
Allergan, Eying More Neurodegenerative Drugs, Gets Right to Buy LTI 01/09/17 Boston
RaNA Expands, Joins Messenger RNA Drug Race With Shire Deal 01/04/17 Boston
Harvard Spinout Magenta, Other Academics Race Toward Better Stem Cell Transplants 11/16/16 Boston
Trump’s Election Stunner: Tech and Life Sciences Leaders React 11/09/16 National
With Reverse Merger, Miragen to Go Public, Get $40M Boost From Investors 11/01/16 Boulder/Denver
Boston’s Life Science Disruptors: The Photos 10/27/16 Boston
Last Chance to Save on Boston’s Life Science Disruptors on 10/20 10/17/16 Boston
Procrastinator’s Special Ends Thursday for Boston’s Life Science Disruptors 10/12/16 Boston
Intellia Execs Talk CRISPR’s Path Forward at Xconomy’s Oct. 20 Event 10/06/16 Boston
Gene Editing, Precision Medicine & More at Disruptors on Oct. 20 09/29/16 Boston
Talk Bio Diversity With Sato, McGuire at Disruptors on Oct. 20 09/22/16 Boston
Biotech Roundup: CRISPR’s 3rd IPO, Gender Diversity, Buyouts & More 09/16/16 National
Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases 09/14/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
CRISPR and More at Boston’s Life Science Disruptors Oct. 20 08/17/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV 08/02/16 Boston
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
Atlas, Novartis Put $27M Into IFM to Battle Cancer, Autoimmune Diseases 06/22/16 Boston
Spero Rolls up More Antibiotics With Vertex Deal 05/25/16 Boston
Across The Board: Ideas To Narrow Biotech’s Gender Gap 05/10/16 National
Page 1 of 20 next page »